As represented in Fig. 7a, tumor growth in mice injected with PLC/PRF/5-shRNA1-HRNR and PLC/PRF/5-shRNA2-HRNR cells was significantly decreased compared with the control group. This evidence concerns the gene HSPG2 and neoplasm.